FDA Accepts Amgen's Supplemental Biologics License Application For The …

FDA Accepts Amgen's Supplemental Biologics License Application For The …

ENBREL was first approved in 1998 for moderate-to-severe rheumatoid arthritis. ENBREL was approved in 1999 to treat moderate-to-severe polyarticular juvenile idiopathic arthritis, in 2002 to treat psoriatic arthritis, for the treatment of patients with

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.